About cnetsadmin

This author has not yet filled in any details.
So far cnetsadmin has created 66 blog entries.

INSPIRATIONAL NET CANCER PATIENT STORY

INSPIRATIONAL NEUROENDOCRINE CANCER PATIENT STORY Long-time CNETS fundraisers Bryde Fresque and Natalie Mezey, share a message of hope! As outlined in this Ottawa Hospital Foundation report, Bryde Fresque [...]

By |2021-05-30T15:17:55-04:00February 11th, 2021|News|Comments Off on INSPIRATIONAL NET CANCER PATIENT STORY

ESMO Guidelines: Lung & Thymic Carcinoids

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Published January 19, 2021 Highlights This updated ESMO Clinical Practice Guideline [...]

By |2021-05-30T15:18:56-04:00February 4th, 2021|Publication|Comments Off on ESMO Guidelines: Lung & Thymic Carcinoids

European Journal of Cancer Article

Article: Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era February 2021 - European Journal of Cancer, Review [...]

By |2021-05-30T15:19:56-04:00January 5th, 2021|Research|Comments Off on European Journal of Cancer Article

INCA NETInfo

INCA GLOBAL NET PATIENT INFO PACK NEW FOR 2020! - NETInfo INCA launches a range of factsheets on NETs that are free to download. These factsheets provide [...]

By |2020-12-26T03:59:28-05:00December 26th, 2020|Education|Comments Off on INCA NETInfo

LUTATHERA® Funded in Ontario

Radiopharmaceutical cancer treatment Lutathera® now available to Ontario patients with midgut neuroendocrine tumours (NETs). The Ontario funding criteria covers the treatment of adult patients with somatostatin receptor-positive (SSR+) midgut NETs [...]

By |2020-10-10T14:14:05-04:00October 10th, 2020|Treatment News|Comments Off on LUTATHERA® Funded in Ontario

LUTATHERA® Funded in Quebec

As of September 30, 2020, the Québec Ministry of Health and Social Services has listed Lutathera on the Liste de Médicaments – Établissements. Lutathera will be reimbursed for GEP-NETs patients [...]

By |2020-10-03T15:46:51-04:00October 3rd, 2020|Treatment News|Comments Off on LUTATHERA® Funded in Quebec

LUTATHERA® Funded in Nova Scotia

As of August 1, 2020, patients with midgut, GEP-NETs will now be eligible for treatment with LUTATHERA® [lutetium (177Lu) oxodotreotide]. This listing covers adult patients with somatostatin receptor-positive (SSR+) midgut [...]

By |2020-09-06T16:03:58-04:00September 4th, 2020|Treatment News|Comments Off on LUTATHERA® Funded in Nova Scotia

#HoofingIt launches at Peggy’s Cove July 1

HOOFING IT - The summer-long fundraiser launched at Peggy's Cove on July 1st. Sharon Needham, lung neuroendocrine cancer survivor and advocate; family, friends, supporters kicked-off HOOFING IT with a [...]

By |2020-07-03T01:17:10-04:00July 3rd, 2020|News|Comments Off on #HoofingIt launches at Peggy’s Cove July 1

#HoofingIt fundraiser launches at Peggy’s Cove July 1

#HoofingIt across Canada to fight one of the fastest-growing class of cancers   Canadian Neuroendocrine Tumour Society (CNETS) launches fundraising challenge at Peggy’s Cove July 1, 2020 HALIFAX­ [...]

By |2020-07-03T00:56:52-04:00July 3rd, 2020|News|Comments Off on #HoofingIt fundraiser launches at Peggy’s Cove July 1

Health Canada Approval of NETSPOT®

Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours NETSPOT® is the first and only kit for the preparation of [...]

By |2020-04-07T21:09:24-04:00April 7th, 2020|News|Comments Off on Health Canada Approval of NETSPOT®
Go to Top